Recent Articles from Business Wire

Researchers at Inocras, a bioinformatics-led precision health company harnessing the power of whole-genome sequencing (WGS) data and proprietary analytics, and the Broad Institute jointly announced the upcoming release of key insights from whole-genome analysis of over 8,000 public cancer whole genomes. This analysis aims to deliver one of the largest genome-wide landscapes of somatic mutations across human pan-cancers.

Dunkin’ is making the unofficial start of wedding season a little sweeter. Just in time for National Proposal Day on March 20, the brand is celebrating its new Wedding Cake MUNCHKINS® Donut Hole Treats and, for one day only, giving away a limited-edition “I Dough” ring box at participating Dunkin’ locations nationwide.

Shenzhen Jewellok Technology Co., Ltd., a leading innovator in high-precision fluid control, today announced the expansion of its Ultra-High Purity (UHP) Liquid Chemical Delivery Systems. Engineered specifically for the rigorous demands of sub-micron semiconductor fabrication and photovoltaic production, these systems provide the extreme contamination control and automation required for modern wafer processing.

Star Mountain Capital, LLC ("Star Mountain"), a rapidly growing, employee-owned investment firm with ~$5 billion in assets under management (“AUM”), is pleased to announce it has expanded its portfolio optimization team with the addition of George Zahringer as Strategic Portfolio Partner. Mr. Zahringer brings over 20 years of operational private equity and private credit investing experience across industry sectors and business cycles as well as advisory and board experience and will work closely with the firm’s investment teams to support value creation initiatives across the portfolio.

Regulatory News:

Hiya, a global leader in trusted voice solutions, has announced the launch of Hiya Secure Branding capabilities within Vodafone’s UK network, making Hiya the only company now operating across all three of the UK’s major mobile operators.

Reply [EXM, STAR: REY] today announced a new partnership agreement with AI leader Mistral AI aimed at accelerating the adoption of local, customisable, secure and enterprise-grade generative AI solutions at scale.

Shifting skills requirements, accelerating demographic change, and the rise of artificial intelligence are reshaping jobs and putting pressure on organizations across Europe to transform their workforces. Yet despite rising investment in HR technology and analytics, most companies still struggle to turn workforce data into meaningful decisions about skills, talent, and future capacity.

Most insurers agree that AI will reshape the industry, but very few have operationalized it. New research from AutoRek finds that 82% of insurers believe AI will dominate the industry’s future, yet only 14% have fully integrated it into their financial operations. At the same time, 44% of firms face settlement periods exceeding 60 days, and 14% of operational budgets are going toward correcting errors caused by manual processes.

Samsung Bioepis Co., Ltd. announced today that the company has entered into a global license, development and commercialization agreement (DCA) with Sandoz for up to five biosimilar candidates under development by Samsung Bioepis, including SB36, a biosimilar candidate referencing Entyvio1 (vedolizumab). The other terms of the agreement remain confidential.

Truffle Capital, a leading European venture capital firm whose mission is to support the creation and growth of companies capable of becoming global leaders, unveils the Truffle MedTech 10 index. This is the first ranking of the top ten publicly traded companies by market capitalization in the pre-commercial and early commercial interventional MedTech sector.

Evinova, a global health tech company with proven, published outcomes for sponsors, sites, and patients, today announced it has achieved the International Organization for Standardization (ISO) 27001:2022 certification, the leading international standard for information security management systems (ISMS). This globally recognized certification confirms that Evinova follows best practices to protect data and manage risks effectively to uphold the highest standards of cybersecurity.

FUJIFILM North America Corporation, Optical Devices Division, today announced the development of three new 4K broadcast zoom lenses: FUJINON UA16x4BERD (“UA16x4”), FUJINON UA30x7.3BERD (“UA30x7.3”), and UA94x8.7BESM (“UA94x8.7”). Each of these newly developed lenses covers a wide range of focal lengths in a single unit, providing strong support for immersive storytelling in a variety of broadcast production environments such as sports broadcasts, concerts, live events, and studio production.

FUJIFILM North America Corporation, Optical Devices Division, announces the availability of its new FUJINON UA22x4.8BERD (“UA22x4.8”), a broadcast zoom lens designed for lightweight versatility ideal for a wide variety of production situations. Initial orders of UA22x4.8 are expected to begin shipping to customers by the end of April 2026.

KKR, a leading global investment firm, Allfleet India Private Limited (“Allfleet”), and PMI Electro Mobility Solutions Private Limited (“PMI Electro”), a manufacturer of electric commercial vehicles in India, today announced the signing of definitive agreements under which KKR-managed funds will commit up to $310 million to form a strategic partnership with Allfleet and PMI Electro to help scale Allfleet’s electric bus (“e-bus”) platform and further advance PMI Electro’s manufacturing capabilities. As part of the investment, KKR will acquire a majority stake in Allfleet and minority stake in PMI Electro. This marks the first KKR Global Climate Transition investment in India and the strategy’s eighth investment globally, including recent investments in Australia.

LTM, the Business Creativity partner to the world’s largest enterprises, has been recognized as the NVIDIA Partner Network (NPN) ‘Rising Star Consulting Partner of the Year’ at NVIDIA GTC 2026. The award recognizes LTM’s strong collaboration with NVIDIA and its growing impact in helping enterprises move from AI experimentation to scalable, enterprise-ready adoption.

U-Haul Company of Hawaii is offering 30 days of free self-storage and U-Box container usage to residents impacted by last week’s Kona Storm and preparing for the next round of severe weather.

Toshiba Electronic Devices & Storage Corporation ("Toshiba") has launched a photovoltaic-output photocoupler, “TLX9920”, in a thin, long-creepage-distance SO6L package, for solid state relays (SSR)[1] in automotive equipment. Volume shipments start today.

The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Alight, Inc. (“Alight” or “the Company”) (NYSE: ALIT) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.

EdgeConneX, a pioneer in global Build-to-Suit and Build-to-Density data center solutions, today announced it has commenced development of its first 200MW, AI-ready data center campus in Greater Osaka. As scheduled, this milestone project in partnership with Kagoya Asset Management, reinforces the company's commitment to the Japanese market and is positioned to support the region's accelerating demand for secure, resilient, and advanced digital infrastructure.

The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Oddity Tech Ltd. (“Oddity” or “the Company”) (NASDAQ: ODD) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.

Coupang, a U.S.-based technology leader, announced at the NVIDIA AI Conference & Expo today that its collaboration with NVIDIA has helped Coupang create an “AI factory” which is accelerating new innovations across the company’s e-commerce logistics and delivery services.

Kolibri Global Energy Inc. (the “Company” or “KGEI”) (TSX: KEI, NASDAQ: KGEI) is providing the results of its December 31, 2025, independent reserves evaluation. All amounts are in US$ unless otherwise stated.

Why: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of SES AI Corporation (NYSE: SES) resulting from allegations that Barclays may have issued materially misleading business information to the investing public.

The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Victoria's Secret & Co. (“Victoria's Secret” or “the Company”) (NYSE: VSCO) for violations of the securities laws.

Bunge Global SA (NYSE: BG) (the “Company” or “Bunge”) today announced that Bunge Limited Finance Corp., its wholly owned finance subsidiary, has successfully priced a public offering of $1.2 billion aggregate principal amount, comprised of two tranches of senior unsecured notes (collectively, the “Senior Notes”), as follows:

The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Arq, Inc. (“Arq” or “the Company”) (NASDAQ: ARQ) for violations of the securities laws.

The City Commission of the City of Weston has granted an affiliate of H&M Development unanimous Site Plan approval for the development of a State of the Art, Class-A, Climate-Controlled Self-Storage facility with 116,062 SF. H&M is expected to break ground in Q3 of 2026.

SoFi Technologies, Inc. (NASDAQ: SOFI), the one-stop shop for digital financial services, today issued the following statement:

Rosen Law Firm, a global investor rights law firm, announces an investigation of potential breaches of fiduciary duties by the directors and officers of Five9, Inc. (NASDAQ: FIVN).

The Board of Woodside Energy has appointed Elizabeth (Liz) Westcott as Chief Executive Officer and Managing Director.

The International Green Industry Hall of Fame (IGIHOF) has announced that it will celebrate eight new inductees as part of its official 2026 Induction Ceremony to be held on Friday, May 1st from 6:00pm – 9:00pm Pacific Time.

Four Corners Property Trust (NYSE:FCPT), a real estate investment trust primarily engaged in the ownership and acquisition of high-quality, net-leased restaurant and retail properties (“FCPT” or the “Company”), is pleased to announce the acquisition of a First Watch property for $2.8 million. First Watch is a daytime dining restaurant chain serving breakfast, brunch, and lunch, with over 600 locations across 32 states. The property is located in a strong retail corridor in Wisconsin and is corporate-operated under a long-term triple net lease. The transaction was priced at a cap rate in range with previous FCPT transactions.

unWired Broadband, a leading high-speed Internet provider in California, announced today the launch of their high-speed Internet service in Lost Hills, CA. This project was developed and executed in partnership with The Wonderful Company and Kern County Board of Supervisors. The service is designed to provide residents in the Lost Hills area with access to affordable, high-speed Internet, while also expanding connectivity to the broader community. To deliver this service, unWired has equipped a telecommunications tower in the community with state-of-the-art fixed wireless technology from Tarana Wireless that offers speeds up to 1 Gig.

Verastem Oncology (Nasdaq: VSTM), a biopharmaceutical company committed to advancing new medicines for patients with RAS/MAPK pathway-driven cancers, today announced multiple abstracts have been accepted for presentation at the American Association for Cancer Research (AACR) Annual Meeting to be held April 17-22, 2026, in San Diego, CA.

The law firm of Kirby McInerney LLP is investigating potential claims against Fulgent Genetics Inc. (“Fulgent” or the “Company”) (NASDAQ:FLGT). The investigation concerns whether the Company and/or members of its senior management may have violated federal securities laws or engaged in other unlawful business practices.

The law firm of Kirby McInerney LLP announces that a class action lawsuit has been filed on behalf of investors who acquired Grocery Outlet Holding Corp. (“Grocery Outlet” or the “Company”) (NASDAQ:GO) securities during the period of August 5, 2025 through March 4, 2026, inclusive (“the Class Period”).

The law firm of Kirby McInerney LLP announces that a class action lawsuit has been filed on behalf of investors who acquired Alight, Inc. (“Alight” or the “Company”) (NYSE:ALIT) securities during the period of November 12, 2024 through February 18, 2026, inclusive (“the Class Period”).

Atkore Inc. (the “Company”) (NYSE: ATKR), a leading manufacturer of electrical products for commercial, industrial, data center, telecommunications, and solar applications, today announced that it will participate in a webcast fireside chat at the previously announced conference:

Recon Analytics has acquired Atom Insights, a device market intelligence firm with operations in Canada and India. Terms were not disclosed.

Infinity Natural Resources, Inc. (“Infinity” or the “Company”) (NYSE: INR) today announced that its subsidiary, Infinity Natural Resources, LLC (the “Issuer”), priced its previously announced private placement (the “Notes Offering”) of $550 million in aggregate principal amount of 7.625% senior notes due 2031 (the “Notes”). The size of this offering was increased from the previously announced $500 million to $550 million. The Notes mature on April 1, 2031, and interest is payable on April 1 and October 1 of each year, beginning on October 1, 2026. The Notes were priced at par. The Notes will be guaranteed on a senior unsecured basis by all of the Issuer’s subsidiaries that guarantee the Issuer’s indebtedness under its revolving credit facility.

Rimini Street, Inc. (Nasdaq: RMNI), a global provider of end-to-end enterprise software support, managed services and Agentic AI ERP innovation solutions, and the leading third-party support provider for Oracle, SAP and VMware software, today announced the following upcoming ROTH Capital Partners Investor Conference, March 23 and 24, 2026, in Laguna Niguel, California:

The Cannabist Company Holdings Inc. (Cboe CA: CBST) (OTCQB: CBSTF) (“The Cannabist Company” or the “Company”), one of the most experienced cultivators, manufacturers, and retailers of cannabis products in the United States, today announced that the ad hoc group of noteholders of the Company’s 9.25% Senior Secured Notes due December 31, 2028 and the 9.00% Senior Secured Convertible Notes due December 31, 2028 (collectively, the “Notes”), which are parties to the previously announced forbearance agreement with the Company, have agreed to a further extension and to forbear from exercising any of their rights and remedies under the amended and restated indenture, as supplemented, governing the Notes and applicable law, until March 25, 2026.

The Natural History Museum of Utah’s (NHMU) free, award‑winning online educator resource, Research Quest, is celebrating two major milestones: its 10‑year anniversary and its 1 millionth learning session delivered worldwide.

Stoke Therapeutics, Inc. (Nasdaq: STOK) is a biotechnology company dedicated to restoring protein expression by harnessing the body’s potential with RNA medicine and has a lead investigational medicine, zorevunersen, in development as a first-in-class potential disease-modifying treatment for Dravet syndrome. The Company today announced that, effective on March 16, 2026, it granted stock options to purchase an aggregate of 58,650 shares of common stock to six new employees, as a material inducement to their employment in accordance with Nasdaq Listing Rule 5635(c)(4).

KBRA assigns preliminary ratings to 71 classes of mortgage pass-through certificates from Sequoia Mortgage Trust 2026-INV2 (SEMT 2026-INV2). The transaction consists of 1,118 investment property mortgages with an aggregate principal balance of $438.4 million as of the March 1, 2026 cut-off date. The collateral is characterized by a weighted average (WA) original credit score of 770 and moderate borrower equity, with a WA original LTV and WA original CLTV of 73.2%.

PIMCO Canada Corp. (“PIMCO Canada”) today announced the 2026 March cash distributions for the ETF series (“ETF Series”) of the PIMCO Canada mutual funds that distribute monthly (“Funds”). Unitholders of record of the ETF Series, at the close of business on March 23, 2026, will receive per-unit cash distribution payable on or about March 31, 2026.

AptarGroup, Inc. (NYSE:ATR), a global leader in drug delivery, dosing and protection technologies, and consumer product dispensing, today announced that Gael Touya, a seasoned global executive with more than 30 years of experience at the company, most recently as Aptar Pharma President, has been appointed President and Chief Executive Officer, effective September 1, 2026. He will succeed Stephan B. Tanda, who has served as President and Chief Executive Officer since 2017. Stephan is expected to continue to work closely with Gael and the Board as an advisor through the end of the year to help ensure a seamless transition as the company enters its next phase of growth. Stephan intends to retire from Aptar’s Board by the end of 2026 and the Board will appoint Gael as a director on September 1, 2026.

Granite Real Estate Investment Trust (“Granite”) (TSX: GRT.UN) announced today that its board of trustees has declared a distribution of CDN $0.2958 per unit for the month of March 2026. The distribution will be paid by Granite on April 15, 2026 to unitholders of record at the close of trading on March 31, 2026.

Aarvik Therapeutics, an innovative, ADC-focused biotechnology company dedicated to engineering precision medicines for cancer therapy, is pleased to announce that it will present two posters and a minisymposium talk at the AACR Annual Meeting 2026. These presentations display the breadth of Aarvik’s capabilities in the ADC space. The AACR Annual Meeting will take place from April 17-22, 2026, in San Diego, California.

JPMorgan Chase & Co. (NYSE: JPM) (“JPMorganChase” or the “Firm”) declared a quarterly dividend on the outstanding shares of the common stock of JPMorganChase. Information can be found on the Firm’s Investor Relations website at https://www.jpmorganchase.com/ir/news.

First Farmers and Merchants Corporation (OTCID: FFMH), the holding company for First Farmers and Merchants Bank, today announced that its Board of Directors has declared the Company’s regular quarterly cash dividend of $0.29 per share, which will be paid on April 16, 2026, to shareholders of record as of April 1, 2026. The dividend represents a 7.4% increase compared with the cash dividend paid during the same period last year.

Verastem Oncology (Nasdaq: VSTM), a biopharmaceutical company committed to advancing new medicines for patients with RAS/MAPK pathway-driven cancers, today announced it will present new long-term AVMAPKI™ FAKZYNJA™ combination therapy (avutometinib capsules; defactinib tablets) data from the Phase 2 RAMP 201 clinical trial at the Society of Gynecologic Oncology (SGO) 2026 Annual Meeting on Women’s Cancers. Additional abstracts accepted for presentation will also be shared at the meeting being held on April 10-13, 2026, in San Juan, Puerto Rico.

As previously announced, JPMorgan Chase & Co. (NYSE: JPM) (“JPMorganChase” or the “Firm”) will host a conference call to review first-quarter 2026 financial results on Tuesday, April 14, 2026 at 8:30 a.m. (ET). The results are scheduled to be released at approximately 7:00 a.m. (ET). The live audio webcast and presentation slides will be available on www.jpmorganchase.com under Investor Relations, Events & Presentations.

Today, Fifth Third Bancorp announced the declaration of cash dividends on its common shares, Series H preferred shares, Series I preferred shares, Series J preferred shares, Series K preferred shares, Series M preferred shares, and Class B Series A preferred shares.

Agenus Inc. (Nasdaq: AGEN), a leader in immuno-oncology, today announced that preliminary results from an investigator-sponsored study evaluating botensilimab (BOT) in combination with balstilimab (BAL) in first-line microsatellite stable colorectal cancer (MSS CRC) will be presented at the American Association for Cancer Research (AACR) Annual Meeting 2026, taking place April 18–23 in San Diego, CA.

Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688) today announced three of the Company’s internally-developed investigational oncology therapies will be presented across four poster sessions at the upcoming American Association for Cancer Research (AACR) Annual Meeting 2026 taking place April 17-22 in San Diego, California. These next-generation candidates include: zocilurtatug pelitecan (zoci, formerly ZL-1310), a DLL3-targeting antibody-drug conjugate (ADC) for small cell lung cancer (SCLC); ZL-6201, a leucine-rich repeat-containing protein 15 (LRRC15) ADC for the treatment of sarcoma and epithelial tumors with LRRC15 expressing cancer-associated fibroblasts (CAFs); and, ZL-1222, a PD-1 and interleukin-12 (IL-12) signaling attenuated mutein agonist immunocytokine for cancer immunotherapy.

Synthekine Inc., an engineered cytokine therapeutics company, today announced that updated clinical and translational data from a Phase 1a/1b clinical trial of its α/β biased IL-2 partial agonist, STK-012, will be presented in an oral presentation at the upcoming American Association for Cancer Research (AACR) Annual Meeting 2026 taking place in San Diego, CA from April 17 - 22, 2026. In this now fully enrolled study, STK-012 is being evaluated in combination with standard-of-care pembrolizumab + chemotherapy in first-line nonsquamous (NSQ) non-small cell lung cancer (NSCLC) patients with features of immune resistance such as PD-L1 negative histology and STK11/KEAP1 mutations.

UnitedHealth Group (NYSE: UNH) will release its first quarter 2026 financial results on Tuesday, April 21, 2026, before the market opens, and will host a teleconference at 8:00 a.m. ET with analysts and investors. This call will be webcast on the Investor Relations page of the company’s website (www.unitedhealthgroup.com). The replay will be available through May 5, 2026, on the website.

Fulgent Genetics, Inc. (NASDAQ: FLGT) (“Fulgent”), a technology-based company with a well-established laboratory services business and a therapeutic development business, today announced the completion of the acquisition of Bako Diagnostics, a premier pathology laboratory, and StrataDx, a premier dermatopathology laboratory, as previously announced on December 22, 2025.

Exact Sciences Corp. (NASDAQ: EXAS), a leading provider of cancer screening and diagnostic tests, today announced four presentations at the 2026 American Association for Cancer Research (AACR) Annual Meeting highlighting new data in molecular residual disease (MRD) testing and multi-cancer early detection (MCED). The meeting will take place from April 17–22, 2026, in San Diego, CA.

Oklo Inc. (NYSE: OKLO) (“Oklo”), an advanced nuclear technology company, today announced the U.S. Department of Energy (DOE) has approved the Nuclear Safety Design Agreement (NSDA) for Atomic Alchemy’s Groves Isotopes Test Reactor in Texas under the DOE’s Reactor Pilot Program (RPP).

Beazer Homes USA, Inc. (the “Company”) (NYSE: BZH) announced that it has entered into a third amendment to its existing senior unsecured revolving credit facility (“Credit Facility”) that increased the available aggregate commitment amount by $160 million to $525 million. The amendment also extends the maturity date of the Credit Facility from March 15, 2028 to March 13, 2030.

Frontier Medicines Corporation, a clinical-stage precision medicines company unlocking the proteome to develop small molecule oncology and immunology drugs against previously undruggable disease-causing targets, today announced that it will present preclinical data on its FMC-242 program, as well as advances from its AI-powered Frontier™ Platform, at the American Association for Cancer Research (AACR) Annual Meeting 2026, taking place April 17-22, 2026, in San Diego. FMC-242 is Frontier’s first-in-class allosteric breaker of the PI3Kα-RAS interaction that is in preclinical development for the treatment of solid tumors driven by RTK activation, RAS mutations and PI3Kα mutations, as both a single agent and in combination with other therapies including KRAS inhibitors.

Ceramic, an AI-native search infrastructure company, today unveiled Supervised Generation at NVIDIA GTC 2026 — a system that augments large language model (LLM) outputs with real-time verification, citations and confidence signals. Supervised Generation is model-agnostic, operating as a trust layer alongside any existing LLM infrastructure, with NVIDIA Nemotron 3 Nano as the featured verification engine. To sign up for our waitlist, visit ceramic.ai, or visit us March 16-19 at booth #4035.

Pheast Therapeutics, a clinical-stage biotechnology company advancing macrophage-directed immunotherapies for cancer, today announced that it will present three abstracts at the American Association for Cancer Research® (AACR) Annual Meeting 2026, taking place April 17–22 in San Diego.

Akamis Bio, a clinical-stage oncology company working to advance the standard of care in colorectal cancer, today announced an upcoming poster presentation of initial clinical data from the FORTRESS study of NG-350A, an oncolytic immunotherapy for the treatment of mismatch repair-proficient (pMMR) locally advanced rectal cancer (LARC), at the American Association for Cancer Research (AACR) Annual Meeting 2026, taking place April 17-22 in San Diego.

SingleCell Biotechnology, a biotechnology company developing technologies to measure tumor cell behavior at single-cell resolution, today announced that data from its platform will be presented at the American Association for Cancer Research (AACR) Annual Meeting 2026, to be held in San Diego, April 17-21, 2026.

Soley Therapeutics, a biotechnology company advancing novel therapeutics informed by integrated cell stress biology, today introduced STX-6398, a first-in-class drug candidate with selective anti-tumor activity through modulation of cytoskeleton-associated protein 2 (CKAP2), a previously undruggable protein central to malignant cancer progression. Preclinical data for STX-6398 will be presented at the American Association for Cancer Research® (AACR) Annual Meeting 2026, taking place April 17-22 in San Diego.

Onchilles Pharma, a private biotech company advancing therapeutics targeting the ELANE pathway, today announced that new preclinical data supporting its systemically delivered NEU-002 program will be presented at the American Association for Cancer Research® (AACR) Annual Meeting 2026, taking place April 17-22 in San Diego. The presentation will highlight the translational development of NEU-002, an engineered therapeutic elastase specifically designed for systemic administration, demonstrating anti-tumor activity via both intravenous and intraperitoneal delivery in solid tumors.

Orum Therapeutics (“Orum” or the “Company”) (KRX: 475830), a biotechnology company pioneering the field of degrader antibody conjugates (DACs), today announced that new preclinical data on ORM-1153, a CD123-targeting DAC designed to selectively deliver a proprietary GSPT1-degrading payload for the treatment of acute myeloid leukemia (AML), will be presented at the American Association for Cancer Research® (AACR) Annual Meeting 2026, taking place April 17-22 in San Diego.

Sixth Street Specialty Lending, Inc. (NYSE: TSLX, or the “Company”) today sent the following letter to its stakeholders.

The law firm of Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Camping World Holdings, Inc. (NYSE: CWH) securities between April 29, 2025 and February 24, 2026, both dates inclusive (the “Class Period”), have until May 11, 2026 to seek appointment as lead plaintiff of the Camping World class action lawsuit. Captioned Siverd v. Camping World Holdings, Inc., No. 26-cv-02710 (N.D. Ill.), the Camping World class action lawsuit charges Camping World as well as certain of Camping World’s top current and former executive officers with violations of the Securities Exchange Act of 1934.

A new state-by-state analysis released today by HEAL Collaborative provides further insight into how hospitals participating in the 340B program are allocating resources. The study, titled "The 340B Drug Pricing Program by State: How Covered Entities Are Failing to Invest in Patient Care," was conducted by Magnolia Market Access and provides the first detailed look at how hospitals participating in the federal 340B drug discount program are utilizing program revenues at the state level.

The Board of Directors of First Internet Bancorp (the “Company”) (Nasdaq: INBK) has declared a quarterly cash dividend of $0.06 per common share. The dividend will be payable on April 15, 2026 to shareholders of record at the close of business on March 31, 2026.